Cargando…
Recent Progress in the Molecular Imaging of Nonalcoholic Fatty Liver Disease
Pathological fibrosis of the liver is a landmark feature in chronic liver diseases, including nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Diagnosis and assessment of progress or treatment efficacy today requires biopsy of the liver, which is a challenge in, e.g....
Autores principales: | Wegrzyniak, Olivia, Rosestedt, Maria, Eriksson, Olof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306605/ https://www.ncbi.nlm.nih.gov/pubmed/34298967 http://dx.doi.org/10.3390/ijms22147348 |
Ejemplares similares
-
Recent Epidemiology of Nonalcoholic Fatty Liver Disease
por: Murag, Soumya, et al.
Publicado: (2021) -
Recent advances in nonalcoholic fatty liver disease metabolomics
por: Kim, Hwi Young
Publicado: (2021) -
Imaging of fibrogenesis in the liver by [(18)F]TZ-Z09591, an Affibody molecule targeting platelet derived growth factor receptor β
por: Wegrzyniak, Olivia, et al.
Publicado: (2023) -
Recent research trends and updates on nonalcoholic fatty liver disease
por: Yoo, Jeong-Ju, et al.
Publicado: (2019) -
Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease
por: Huh, Youn, et al.
Publicado: (2022)